CEL-SCI Corporation CVM
At closeNov 10, 2026, 4:00 PM EST
After hours · Nov 10, 4:00 PM ET
- YTD
- -73.19%
- 1 year
- -80.39%
Discussion (164)
Sign in to join the discussion

Aint No mountain high enough
I have posted before I felt something was very odd here. Even with marginal effectiveness multikine should be approved bc of ZERO TOXICITY. These are cancer patients - a high % of whom die. Let’s put on a tinfoil hat. The FDA is not about health - otherwise they would not approve a toxic, ineffective vaccine for children to treat a disease that causes only minor symptoms. Plus CVM is a little company - not a big pharma giant. We have seen with Pfizer how big pharma funds and controls the FDA. Those in power do not want this drug on the market - at least not by lowly CVM.
There is something very wrong here. Even with marginal improvements, a cancer drug with NO SIDE EFFECTS should be approved. We have seen from the COVID vaccine approval (and suppression of reporting of side effects) how corrupt the FDA is.
FDA purposeful slow walk to allow Big Pharma to scoop up company at discount.
Hopefully Europe less corrupt and will approve which will force hand of FDA (or buyer)
Big medicine 3 letter agencies all corrupt and bought/paid for by Big Pharma
While I like Ted’s post, where are the speculators? Option prices not pricing in much good news.
There are ZERO catalysts for stock prices.
We could see a negotiated settlement to Ukraine war as kind of October surprise to try and help Dems. Obvious catalyst would be to increase energy exploration (like England is), but that won’t happen with Biden. All we can really hope for is gridlock after the election, which tends to be good for the market. Nothing is going up, but it may establish a tradable floor.
As we have seen from the fraud and cover-up associated with the COVID vaccine, big pharma and the FDA are in bed together. It is not unreasonable to think that the FDA will withhold approval for multikine and bleed them of funds, enabling a large multinational company to scoop CVM up at a bargain. There is proven efficacy at 5 year survival with NO TOXICITY. Yet the FDA pushes a vaccine with zero efficacy for children (in fact it is dangerous for this age group) and withholds effective cancer treatments for adults. CVM is a $150-$200 stock that will likely be sold for 1/3 of that. I hope I am wrong but I just don’t otherwise understand the delays.
Let’s hope MK has more luck than Trump and a future unlike Trump
